FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/094126 [Registered on: 02/09/2025] Trial Registered Prospectively
Last Modified On: 02/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Study of Prediabetes in Overweight People Living in Kanpur City 
Scientific Title of Study   Prediabetes among Overweight Individuals residing in an Urban Area of Kanpur: A Cross-Sectional Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Yashika Bhardwaj 
Designation  PhD Scholar (Medical Laboratory Technology) 
Affiliation  School of Health Sciences, Chhatrapati Shahu Ji Maharaj University, Kanpur, Uttar Pradesh, India 
Address  Room No: SHS 133, Department of Microbiology, School of Health Sciences, Chhatrapati Shahu Ji Maharaj University, Kanpur, Uttar Pradesh, India

Kanpur Nagar
UTTAR PRADESH
208024
India 
Phone  8445181791  
Fax    
Email  yashikabhardwaj62@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR MUNISH RASTOGI 
Designation  Associate Professor 
Affiliation  School of Health Sciences, Chhatrapati Shahu Ji Maharaj University 
Address  Room No: SHS 135, Department of Microbiology. School of Health Sciences, Chhatrapati Shahu Ji Maharaj University, Kanpur, Uttar Pradesh, India

Kanpur Nagar
UTTAR PRADESH
208024
India 
Phone  9450164012  
Fax    
Email  munishkanuni@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Yashika Bhardwaj 
Designation  PhD Scholar (Medical Laboratory Technology) 
Affiliation  School of Health Sciences, Chhatrapati Shahu Ji Maharaj University, Kanpur, Uttar Pradesh, India 
Address  Room No: SHS 133, Department of Microbiology, School of Health Sciences, Chhatrapati Shahu Ji Maharaj University, Kanpur, Uttar Pradesh, India

Kanpur Nagar
UTTAR PRADESH
208024
India 
Phone  8445181791  
Fax    
Email  yashikabhardwaj62@gmail.com  
 
Source of Monetary or Material Support  
School of Health Sciences, CSJM University, Kalyanpur, Kanpur, 208024, Uttar Pradesh, India 
 
Primary Sponsor  
Name  NO 
Address  NIL 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Yashika Bhardwaj  Chhatrapati Shahu Ji Maharaj University   Room No: SHS 133, Department of Microbiology
Kanpur Nagar
UTTAR PRADESH 
8445181791

yashikabhardwaj62@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Human Ethical Committee, Chhatrapati Shahu Ji Maharaj University  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Individuals who are overweight, as indicated by a higher BMI, face an increased risk of developing prediabetes 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Both 
Details  1. Male & female subjects age between 18-40 years.
2. Have no known metabolic or endocrine disorders.
3. Be willing to complete questionnaires.
 
 
ExclusionCriteria 
Details  1. Are critically ill or pregnant.
2. Have undergone significant lifestyle changes in the last six months (e.g., major weight loss/gain, started a new exercise program).
3. Have a history of substance abuse within the last year (e.g., drugs or alcohol).
4. Have any physical disability that limits mobility or prevents participation in the anthropometric assessments.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The proportion of prediabetes among overweight urban adults in Kanpur was assessed at baseline using fasting and laboratory analysis, and is expressed as the percentage of participants who met the prediabetes diagnostic criteria at the time of screening.
 
All outcomes will be measured at baseline (initial screening and sample collection). Predictive model outcomes will be generated after data analysis is completed. 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="250"
Sample Size from India="250" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This cross-sectional study aims to estimate the prevalence of prediabetes among overweight young adults residing in urban Kanpur. It will investigate the impact of lifestyle habits such as diet, physical activity, sleep quality, and stress on hormonal and biochemical markers associated with prediabetes. Data will be collected through questionnaires, anthropometric measurements, and blood samples. Advanced artificial intelligence techniques will be used to analyze the data, identify key determinants, and develop a predictive model for prediabetes risk. The study seeks to provide insights to support early interventions and preventive strategies tailored for young adults at risk of developing type 2 diabetes. 
Close